Alpha Tau Medical (NASDAQ: DRTS) CEO details equity holdings
Rhea-AI Filing Summary
Alpha Tau Medical Ltd. director and CEO Uzi Sofer has filed an initial statement of holdings. He reports direct ownership of 1,250,941 Ordinary Shares, plus 4,680 Restricted Share Units that will vest in full upon the earlier of one year from March 9, 2026 or the next Annual General Meeting, subject to continued service.
Sofer also holds a large portfolio of stock options over Ordinary Shares at exercise prices ranging from $1.10 to $11.50, with expirations between 2027 and 2036. According to the footnotes, some of these options are already fully vested, while others vest either in full on a one-year schedule tied to March 9, 2026 and the next Annual General Meeting, or in equal quarterly installments over four years starting January 1, 2026, all contingent on his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
Footnotes (4)
- F1. These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
- F2. These are options to acquire ordinary shares, which have fully vested as of the date hereof.
- F3. These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
- F4. These are options to acquire ordinary shares, which options which vest in quarterly equal installments for a period of four years commencing January 1, 2026, subject to the Reporting Person's continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
